期刊文献+

高效液相色谱法检测防脱、育发类化妆品中的非那雄胺 被引量:8

Determination of finasteride in anti-calvous hair cosmetics by high performance liquid chromatography
下载PDF
导出
摘要 采用高效液相色谱法测定防脱、育发类化妆品中的非那雄胺,色谱条件为ZorbaxExtendC18柱(250mm×4.6mm,5μm),流动相为乙腈/10mmol·L^-1磷酸二氢钾梯度洗脱体系,流速为1.0mL·min^-1,检测波长为220nm,柱温为30℃。实验结果表明,在此条件下非那雄胺在0.8~20mg·L^-1与相应的峰面积具有良好的线性关系(R^2=0.9990),回收率为90.3%~102.0%。 A reversed - phase high performance liquid chromatography for the determination of finasteride in anti -calvous hair cosmetics was established. The sample was analyzed on a Agilent Zorbax Extend Cts column (250 mm× 4.6 mm, 5 μm) with detecting wavelength of 220 nm at 30 ℃, and eluted by mobile phase composed of acetonitrile (CH3CN) and KH2PQ (10 mmol·L^-1) with a gradient model,at a flow rate 1.0 mL min ^-1. Results showed that as the mass concentration of finasteride is in the range of 0. 8 - 20 mg·L^-1, the relationship between the mass concentration and the corresponding peak area shows good linearity (R2 = 0. 999 0). The recoveries of finasteride achieve 90.3 % - 102. 0%.
出处 《日用化学工业》 CAS CSCD 北大核心 2014年第1期54-56,共3页 China Surfactant Detergent & Cosmetics
关键词 发用化妆品 非那雄胺 高效液相色谱法 sterile hair cosmetics finasteride high performance liquid chromatography
  • 相关文献

参考文献5

二级参考文献9

  • 1MHRA. Finasteride and the risk of male breast cancer [ EB/OL]. 2009-12493. http://www, mhra. gov. uk/Safetyinformation/ Safetywamingsalertsandrecalls/Safetywarningsandmessagesformedicines/CON065479.
  • 2MHRA. Drug Safety Update. Finasteride: potential risk of male breast cancer [ EB/OL]. 2009-12. http ://www. mhra. gov. uk/Publications/Safetyguidance/DrugSafetyUpdate/CON065444.
  • 3Ptacek P, Macek J, Klima J. Determination of finasteride in human plasma by liquid -liquid extraction and high -performance liquid chromatography. J Chromatogr B, 2000,738 (2) :305.
  • 4Constanzer ML, Chavez CM, Matuszewski BK. Picogram determination of finasteride in human plasma and semen by high - performance liguid chromatography with atmospheric - pressure chemicalionization tandem mass spectrometry. J Chromatogr B, 1994,658(2) :281.
  • 5Ohtawa M, Morikawa H, Shimazaki J. Pharmacokinetics and biochemical efficacy after single and multiple oral administration of N - (2 -methyl - 2 - propyl) - 3 - oxo - 4 - aza - 5 alpha - androst - 1 - ene-17beta- carboxamide, a new type of specific competitive inhibitor of testosterone 5 alpha - reducatase,in volunteers. Eur J Drug Metab Pharmacokinet, 1991,16 ( 1 ) :5.
  • 6Causon R. Validation of chromatographic methods in biomedical analysis. - Viewpoint and discussion. J Chromatogr B, 1997,689 ( 1 ) :175.
  • 7杨淑霞,季素珍,陈伟,王丹,汪科,王卉,王爱平,韩钢文,刘玲玲,杨海珍,朱学骏.非那雄胺治疗男性雄激素源性秃发的随机、双盲、安慰剂对照临床研究[J].中国临床药理学杂志,2002,18(1):3-6. 被引量:12
  • 8赵辨.保法止~(非那雄胺片)[J].临床皮肤科杂志,2002,31(5):307-307. 被引量:11
  • 9程建玉,陈学荣.雄激素源性脱发[J].医疗装备,2004,17(2):26-28. 被引量:5

共引文献15

同被引文献64

引证文献8

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部